**Core Concept**
The question is testing the student's knowledge of the cardiotoxic effects of certain antineoplastic drugs. Antineoplastic drugs are a class of medications used to treat cancer, and some of these drugs can have severe cardiac side effects.

**Why the Correct Answer is Right**
The correct answer is associated with a high risk of cardiotoxicity due to its ability to cause direct damage to the myocardium and cardiac conduction system. This drug is a potent inhibitor of topoisomerase II, an enzyme essential for DNA replication and cell division. The inhibition of topoisomerase II leads to the formation of free radicals and the generation of reactive oxygen species, which can cause oxidative stress and damage to cardiac cells. The drug's mechanism of action also involves the induction of apoptosis in cardiac myocytes, leading to cardiomyopathy and cardiac failure.

**Why Each Wrong Option is Incorrect**
**Option A:** This drug is not typically associated with high cardiac toxicity and is often used to treat various types of cancer, including leukemia and lymphoma.
**Option B:** While this drug can cause cardiac side effects, it is not as strongly associated with cardiac toxicity as the correct answer.
**Option C:** This drug is not known to have significant cardiotoxic effects and is often used to treat solid tumors.

**Clinical Pearl / High-Yield Fact**
It's essential to note that the correct answer is a potent inhibitor of topoisomerase II, and its use requires careful monitoring of cardiac function to prevent cardiac toxicity.

**Correct Answer: D. Anthracyclines**